General
Preferred name
AGL 2043
Synonyms
P&D ID
PD041970
CAS
226717-28-8
Tags
drug candidate
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
This is compound 13 in .
AGL 2043 is a potent, reversible, ATP-competitive inhibitor of type III receptor tyrosine kinases (PDGFR, CSFR, Kit, FLT3 receptor family). (GtoPdb)
AGL 2043 is a potent, reversible, ATP-competitive inhibitor of type III receptor tyrosine kinases (PDGFR, CSFR, Kit, FLT3 receptor family). (GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
12
Molecular Weight
280.08
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
1
Ring Count
4
Aromatic Ring Count
4
cLogP
3.55
TPSA
43.6
Fraction CSP3
0.13
Chiral centers
0.0
Largest ring
6.0
QED
0.54
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
